KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma
about
P1343
Seroprevalence and risk factors of Kaposi's sarcoma-associated herpesvirus infection among the general Uygur population from south and north region of Xinjiang, ChinaHuman herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cellsKaposi's sarcoma-associated herpesvirus vCyclin open reading frame contains an internal ribosome entry siteHuman herpesvirus 8--a novel human pathogenIdentification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirusIdentification of a novel cellular transcriptional repressor interacting with the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirusNucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigenKaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomesHuman herpesvirus 6The viral etiology of AIDS-associated malignanciesDevelopment of real-time NASBA assays with molecular beacon detection to quantify mRNA coding for HHV-8 lytic and latent genes.Risk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control studyThe conundrum of causality in tumor virology: the cases of KSHV and MCVActin dynamics regulate multiple endosomal steps during Kaposi's sarcoma-associated herpesvirus entry and trafficking in endothelial cellsThe ubiquitin/proteasome system mediates entry and endosomal trafficking of Kaposi's sarcoma-associated herpesvirus in endothelial cellsThe Role of Infectious Agents in the Etiology of Ocular Adnexal NeoplasiaMolecular virology of Kaposi's sarcoma-associated herpesvirusSeroprevalence of Kaposi's sarcoma-associated herpesvirus and risk factors in Xinjiang, ChinaKaposi's Sarcoma–Associated Herpesvirus Immunoevasion and Tumorigenesis: Two Sides of the Same Coin?De novo infection with rhesus monkey rhadinovirus leads to the accumulation of multiple intranuclear capsid species during lytic replication but favors the release of genome-containing virions.Capsid structure of Kaposi's sarcoma-associated herpesvirus, a gammaherpesvirus, compared to those of an alphaherpesvirus, herpes simplex virus type 1, and a betaherpesvirus, cytomegalovirusComplex alternative cytoplasmic protein isoforms of the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 generated through noncanonical translation initiation.Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus.Transcriptional analysis of latent and inducible Kaposi's sarcoma-associated herpesvirus transcripts in the K4 to K7 region.EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors.Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa.Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda.A Phase Ib Study of Sorafenib (BAY 43-9006) in Patients with Kaposi Sarcoma.High human herpesvirus 8 (HHV-8) prevalence, clinical correlates and high incidence among recently HIV-1-infected subjects in Sao Paulo, Brazil.Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivateMolecular biology of KSHV in relation to AIDS-associated oncogenesis.Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNAIdentification and characterization of Kaposi's sarcoma-associated herpesvirus K8.1 virion glycoproteinHigh-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populationsKinetics of Kaposi's sarcoma-associated herpesvirus gene expression.Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein.High human herpesvirus 8 seroprevalence in the homosexual population in SwitzerlandPerspective on Kaposi's sarcoma: facts, concepts, and conjectures.KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.
P2860
Q21245098-E431F33A-A9F1-4BB7-80BF-C592BE06F922Q24527215-77FD13C8-E238-4083-8535-0CE6EE9190CEQ24529088-19703C8D-79B2-4C28-8713-B4D0A99E6156Q24530670-A78FD4D9-EECA-4696-9D12-FBA11AB857EBQ24561400-A96094F5-5914-4B2E-826C-20BA69F183CEQ24646461-59C2F048-4C92-4174-89D2-A753A38C6672Q24650427-114F7322-E649-4464-A8C5-1E478916B58AQ24672438-137C9427-B075-4FB5-80A5-8D7287C024E3Q24673761-CFDD1A2F-5C75-4F7F-8A94-E7142CBE2AFEQ24683663-6E5C4852-DCE6-4DFD-890E-B31124B28640Q24685892-5DCB9FEB-A90D-479D-87FA-D872A3590289Q24803532-29F41996-3CF0-42A6-B3E1-7D783C4087A4Q24804288-ED3987FD-531A-49E4-9D98-50BE532C099AQ26863112-3AB6CE29-B2BF-44F4-9D8D-5CEE74228C6FQ27316598-4788C962-E6D5-44F6-95FA-4EB639192B54Q27345534-9A23F903-28CE-4BAC-A994-F8CFFCDA4E88Q27486618-3FFA3C94-3B57-4DEB-A7B7-AC95E5D2AF5AQ28363323-399A3549-0618-4BBC-BD2C-3DE884353BA2Q28750969-EC00E84D-BCB5-4830-9975-AE5CE9D31BD6Q29394711-A280C8E8-C82A-4647-9B81-E88DE38E0C43Q30311978-0BA6825A-BB7D-4B05-A2A5-8AEE3DCAE6D6Q30453457-9CD026B3-0741-43A9-952F-1A1253D89594Q30535717-DBB0F882-3969-46B3-9D3A-4E91BFF63F78Q31156919-8E4061D1-5005-4E62-9255-C24262A43B3DQ33227754-B4CADC41-32E8-4E5B-8B70-71F791484472Q33261811-F6CF885E-AD12-4AD1-A08C-46DEF5F8DF35Q33360459-D98E033C-8C83-40A3-8AEB-BF79C9B0D3C7Q33401242-ED8F6022-73B6-41D3-9D14-6ACBCEC903BBQ33440392-FAC471AF-3C87-44A6-8F68-18230FD11EABQ33455708-9F8D6014-BAED-45AE-BF33-2C0A63D4857CQ33558299-8D8111F1-C51A-4CA6-899C-222CA0B20411Q33560572-20BC9106-03BF-4F5A-9A83-DC3A0695E64FQ33625562-59906CBD-FB63-4404-A318-B1B497219F3BQ33641311-E18D1E1E-8AD5-4DCB-86C8-FC569D9AD709Q33647633-94EF02A0-EEEA-4038-97B1-36335290734DQ33653424-4891D18C-8BEB-4FDD-A31F-D620A5C41F19Q33669136-96DF01E7-4E65-4629-8492-0105900587F2Q33671148-36B66A8B-9FC2-48A9-B2BD-2378A3ED9065Q33724002-A853F0E9-3182-47D3-8483-CA4F743FB3C3Q33761091-E751198C-93F8-4683-9108-343921548CEB
P2860
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma
description
1996 nî lūn-bûn
@nan
1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma
@ast
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma
@en
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma
@nl
type
label
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma
@ast
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma
@en
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma
@nl
prefLabel
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma
@ast
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma
@en
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma
@nl
P2093
P2860
P50
P921
P3181
P356
P1433
P1476
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma
@en
P2093
C Parravicini
C R Rinaldo
P2860
P2888
P304
P3181
P356
10.1038/NM0896-925
P407
P4510
P577
1996-08-01T00:00:00Z